Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15466525 | 1.00 | EPHX2 (0.36) | EPHX2 | |
| SCHEMBL15466527 | 1.00 | EPHX2 (0.36) | EPHX2 | |
| SCHEMBL439944 | 1.00 | EPHX2 (0.36) | EPHX2 | |
| SCHEMBL22776055 | 1.00 | EPHX2 (0.36) | EPHX2 | |
| SCHEMBL2092396 | 0.97 | EPHX2 (0.35) | EPHX2 | |
| SCHEMBL15466425 | 0.74 | CHRNB2 (0.31) | — | |
| SCHEMBL3773537 | 0.72 | — | — | |
| SCHEMBL875052 | 0.69 | — | — | |
| SCHEMBL15466342 | 0.69 | SMN1; SMN2 (0.34) | — | |
| SCHEMBL8141299 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139891-B1 | 4-SUBSTITUTED AZAADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF | ABBOTT LAB (US) | 2012-09-05 | — | — | EP | claimed |
| US-20250236945-A1 | Method of Implanting Atoms in a Substrate and Method of Forming a Quantum Register | UNIVERSITAET ULM (DE) | 2025-07-24 | — | — | US | disclosed |
| EP-4423326-A1 | METHOD OF IMPLANTING ATOMS IN A SUBSTRATE AND METHOD OF FORMING A QUANTUM REGISTER | SaxonQ GmbH (DE) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023072384-A1 | METHOD OF IMPLANTING ATOMS IN A SUBSTRATE AND METHOD OF FORMING A QUANTUM REGISTER | UNIVERSITÄT ULM (DE) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023073060-A1 | METHOD OF IMPLANTING ATOMS IN A SUBSTRATE AND METHOD OF FORMING A QUANTUM REGISTER | UNIVERSITAET ULM (DE) | 2023-05-04 | — | — | WO | disclosed |
| CN-115215725-A | Method for preparing lavender acetate and lavender alcohol | 宋晓瑜 | 2022-10-21 | — | — | CN | disclosed |
| US-9983218-B2 | Indole and indoline derivatives and methods of use thereof | ABBVIE INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-9983218-B2 | Indole and indoline derivatives and methods of use thereof | ABBVIE INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-9983218-B2 | Indole and indoline derivatives and methods of use thereof | ABBVIE INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-20180024144-A1 | INDOLE AND INDOLINE DERIVATIVES AND METHODS OF USE THEREOF | ABBVIE INC. (US) | 2018-01-25 | — | — | US | disclosed |
| EP-0652879-B1 | 1-AZAADAMANTANE DERIVATIVES AS 5-HT4 AGONISTS OR ANTAGONISTS AND/OR 5-HT3 ANTAGONISTS | SEARLE & CO (US) | 1999-04-14 | — | — | EP | disclosed |
| US-5840903-A | 5-HT3 AND 5-HT4 AGONISTS AND ANTAGONISTS | G. D. SEARLE & CO. (US) | 1998-11-24 | — | — | US | disclosed |
| US-5643917-A | GASTROINTESTINAL DISORDERS, 5HT ANTAGONISTS OR AGONISTS, COGNITION ACTIVATORS OR CNS DISORDERS | G. D. SEARLE & CO. (US) | 1997-07-01 | — | — | US | disclosed |
| US-5534521-A | SEROTONIN ANTAGONISTS | G. D. SEARLE & CO. (US) | 1996-07-09 | — | — | US | disclosed |
| US-5521193-A | SEROTONIN AGONISTS AND ANTAGONISTS | G. D. SEARLE & CO. (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0652879-A1 | 1-AZAADAMANTANE DERIVATIVES AS 5-HT AGONISTS OR ANTAGONISTS | G.D. SEARLE & CO. (US) | 1995-05-17 | — | — | EP | disclosed |
| WO-1994002482-A1 | 1-AZAADAMANTANE DERIVATIVES AS 5-HT AGONISTS OR ANTAGONISTS | G.D. SEARLE & CO. (US) | 1994-02-03 | — | — | WO | disclosed |
| WO-1994000454-A1 | BENZIMIDAZOLE COMPOUNDS | G.D. SEARLE & CO. (US) | 1994-01-06 | — | — | WO | disclosed |
| US-4816453-A | N-heterocyclic derivatives of benzamides and their use in treating gastric and intestinal disorders | BEECHAM GROUP, P.L.C. (GB) | 1989-03-28 | — | — | US | disclosed |
| EP-0227215-A1 | 1-Azatricycloalkylbenzamides, process for their preparation, and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180024144-A1 | INDOLE AND INDOLINE DERIVATIVES AND METHODS OF USE THEREOF | IDO1, IDO2, TPH1 | EPHX2 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.